Do we always need anticoagulation before cardioversion of atrial fibrillation in ladies?

Kaynakça (1)

1. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014; 130: e199-267. [CrossRef] 2. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. ESC Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA). Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2369-429. [CrossRef] 3. Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719-47. [CrossRef] 4. Marinigh R, Lip GYH, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients. implications for thromboprophylaxis. J Am Coll Cardiol 2010; 56: 827-37. [CrossRef] 5. Verma A, Cairns JA, Mitchell LB, Macle L, Stiell IG, Gladstone D, et al. 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. Can J Cardiol 2014; 30: 1114-30. [CrossRef] 6. Airaksinen KEJ, Nammas W, Nuotio I. Cardioversion in acute atrial fibrillation without anticoagulation. JAFIB 2013-2014; 6: 71-3. 7. Hansen ML, Jepsen RMHG, Olesen JB, Ruwald MH, Huth M, Karasoy D, et al. Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy. Europace 2015; 17: 18-23. [CrossRef] 8. Airaksinen KE, Grönberg T, Nuotio I, Nikkinen M, Ylitalo A, Biancari F, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: The FinCV (Finnish CardioVersion) Study. J Am Coll Cardiol 2013; 62: 1187-92. [CrossRef] 9. Nuotio I, Hartikainen JEK, Grönberg T, Biancari F, Airaksinen KEJ. Time to cardioversion for acute atrial fibrillation and thromboembolic complications. JAMA 2014; 312: 647-9. [CrossRef] 10. Olesen JB, Fauchier IB, Lane DA, Thailandier S, Lip GYH. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fribrillation. The Loire Valley Atrial Fibrillation Project. Chest 2012; 141: 147. [CrossRef